252 related articles for article (PubMed ID: 7173202)
1. Estrogen-receptor--DNA interaction. Difference between activation by estrogen and antiestrogen.
Evans E; Baskevitch PP; Rochefort H
Eur J Biochem; 1982 Nov; 128(1):185-91. PubMed ID: 7173202
[TBL] [Abstract][Full Text] [Related]
2. Interaction of the antiestrogen [3H]H1285 with the two forms of the molybdate-stabilized calf uterine estrogen receptor.
Keene JL; Ruh MF; Ruh TS
J Steroid Biochem; 1984 Dec; 21(6):625-31. PubMed ID: 6527530
[TBL] [Abstract][Full Text] [Related]
3. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
[TBL] [Abstract][Full Text] [Related]
4. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
Dix CJ; Jordan VC
Endocrinology; 1980 Dec; 107(6):2011-20. PubMed ID: 7191796
[TBL] [Abstract][Full Text] [Related]
5. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate.
Borgna JL; Scali J
J Steroid Biochem; 1988 Oct; 31(4A):427-36. PubMed ID: 3050278
[TBL] [Abstract][Full Text] [Related]
6. Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor.
Tate AC; Greene GL; DeSombre ER; Jensen EV; Jordan VC
Cancer Res; 1984 Mar; 44(3):1012-8. PubMed ID: 6692388
[TBL] [Abstract][Full Text] [Related]
7. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
8. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
Pavlik EJ; Nelson K; Srinivasan S; Powell DE; Kenady DE; DePriest PD; Gallion HH; van Nagell JR
Cancer Res; 1992 Aug; 52(15):4106-12. PubMed ID: 1638522
[TBL] [Abstract][Full Text] [Related]
9. High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite.
Borgna JL; Rochefort H
Mol Cell Endocrinol; 1980 Oct; 20(1):71-85. PubMed ID: 7439523
[TBL] [Abstract][Full Text] [Related]
10. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
[TBL] [Abstract][Full Text] [Related]
11. Unique molecular properties of a urea- and salt-stable DNA-binding estrogen receptor dimer covalently labeled with the antiestrogen [3H]desmethylnafoxidine aziridine. A comparison with the estrogen-receptor complex.
Hutchens TW; McNaught RW; Yip TT; Suzuki T; Li CM; Besch PK
Mol Endocrinol; 1990 Feb; 4(2):255-67. PubMed ID: 2330004
[TBL] [Abstract][Full Text] [Related]
12. Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction.
Pavlik EJ; van Nagell JR; Nelson K; Gallion H; Donaldson ES; Kenady DE; Baranowska-Kortylewicz J
Endocrinology; 1986 May; 118(5):1924-34. PubMed ID: 2422013
[TBL] [Abstract][Full Text] [Related]
13. High-affinity binding of the antiestrogen [3H]tamoxifen to the 8S estradiol receptor.
Capony F; Rochefort H
Mol Cell Endocrinol; 1978; 11(2):181-98. PubMed ID: 680340
[TBL] [Abstract][Full Text] [Related]
14. Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements.
Klinge CM; Studinski-Jones AL; Kulakosky PC; Bambara RA; Hilf R
Mol Cell Endocrinol; 1998 Aug; 143(1-2):79-90. PubMed ID: 9806352
[TBL] [Abstract][Full Text] [Related]
15. Acceptor sites on chromatin for receptor bound by estrogen versus antiestrogen in antiestrogen-sensitive and -resistant MCF-7 cells.
Singh RK; Ruh MF; Butler WB; Ruh TS
Endocrinology; 1986 Mar; 118(3):1087-95. PubMed ID: 3948766
[TBL] [Abstract][Full Text] [Related]
16. Estradiol and tamoxifen interaction at receptor sites at 37 C.
Fishman JH
Endocrinology; 1983 Sep; 113(3):1164-6. PubMed ID: 6191968
[TBL] [Abstract][Full Text] [Related]
17. Antiestrogen pharmacology and mechanism of action.
Katzenellenbogen BS; Miller MA; Eckert RL; Sudo K
J Steroid Biochem; 1983 Jul; 19(1A):59-68. PubMed ID: 6887873
[TBL] [Abstract][Full Text] [Related]
18. Antagonistic effect of triphenylethylenic antiestrogens on the association of estrogen receptor to calmodulin.
Bouhoute A; Leclercq G
Biochem Biophys Res Commun; 1992 May; 184(3):1432-40. PubMed ID: 1590802
[TBL] [Abstract][Full Text] [Related]
19. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone.
Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A
Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202
[TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular mechanism of action of antiestrogens.
Rochefort H; Borgna JL; Evans E
J Steroid Biochem; 1983 Jul; 19(1A):69-74. PubMed ID: 6887874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
